MIA · 2025-26
Bam Adebayo
- PTS/G
- 20.1
- REB/G
- 10.0
- AST/G
- 3.2
- TS%
- 55.1%
- RNP
- 153.3
- PRF
- 2042.0
Season RNP is higher than about ~92% of qualified players (same season as the leaderboard: 549 players with 5+ GP; rank 44). Population & rules →
Running Net Points are not opponent-adjusted. Use home/away and opponent labels as schedule context, not as adjustments to the stat.
Latest game — possession RNP
Sun · Apr 12 · vs ATLHome · W 143–117
Game log
2025-26 · 73 games · through Sun · Apr 12
| Date | Opp | Res | MIN | FG | 3P | FT | PTS | REB | AST | RNP | TS% | PRF |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | vs ATL | W | 29.2 | 11/18 | 1/4 | 2/4 | 25 | 10 | 3 | 8.0 | 63.3% | 33.0 |
| 2026-04-10 | @ WAS | W | 38.5 | 7/14 | 3/6 | 3/3 | 20 | 11 | 8 | 1.4 | 65.3% | 40.0 |
| 2026-04-09 | @ TOR | L | 37.5 | 9/14 | 2/4 | 4/5 | 24 | 11 | 8 | 4.5 | 74.1% | 42.0 |
| 2026-04-07 | @ TOR | L | 36.5 | 2/13 | 1/7 | 2/2 | 7 | 9 | 3 | -10.1 | 25.2% | 13.0 |
| 2026-04-04 | vs WAS | W | 24.2 | 3/6 | 2/4 | 6/7 | 14 | 9 | 7 | -0.0 | 77.1% | 30.0 |
| 2026-04-01 | vs BOS | L | 37.9 | 10/21 | 5/10 | 4/8 | 29 | 10 | 2 | -1.1 | 59.1% | 35.0 |
| 2026-03-30 | vs PHI | W | 42.0 | 5/11 | 1/4 | 12/13 | 23 | 16 | 6 | 13.1 | 68.8% | 35.0 |
| 2026-03-29 | @ IND | L | 33.0 | 6/16 | 0/3 | 3/4 | 15 | 12 | 3 | -4.6 | 42.2% | 22.0 |
| 2026-03-27 | @ CLE | L | 30.7 | 3/14 | 1/8 | 7/8 | 14 | 16 | 3 | -3.5 | 40.0% | 22.0 |
| 2026-03-25 | @ CLE | W | 33.1 | 6/19 | 1/9 | 4/5 | 17 | 10 | 7 | 1.6 | 40.1% | 35.0 |
| 2026-03-23 | vs SAS | L | 28.7 | 5/17 | 2/10 | 6/6 | 18 | 3 | 4 | -2.3 | 45.8% | 29.0 |
| 2026-03-21 | @ HOU | L | 45.0 | 12/21 | 2/4 | 6/8 | 32 | 21 | 4 | 7.3 | 65.3% | 43.0 |
| 2026-03-19 | vs LAL | L | 37.8 | 9/19 | 3/8 | 7/10 | 28 | 10 | 2 | 2.2 | 59.8% | 33.0 |
| 2026-03-14 | vs ORL | L | 38.5 | 6/15 | 2/7 | 6/10 | 20 | 7 | 1 | 3.0 | 51.5% | 22.0 |
| 2026-03-12 | vs MIL | W | 35.0 | 6/20 | 0/5 | 9/13 | 21 | 8 | 2 | 5.8 | 40.8% | 26.0 |
| 2026-03-10 | vs WAS | W | 41.9 | 20/43 | 7/22 | 36/43 | 83 | 9 | 3 | 39.0 | 67.0% | 92.0 |
| 2026-03-08 | vs DET | W | 34.0 | 7/17 | 4/10 | 6/6 | 24 | 9 | 6 | 6.4 | 61.1% | 39.0 |
| 2026-03-06 | @ CHA | W | 38.5 | 10/26 | 0/5 | 4/5 | 24 | 12 | 4 | 2.4 | 42.6% | 35.0 |
| 2026-03-05 | vs BKN | W | 24.9 | 7/15 | 0/4 | 7/8 | 21 | 7 | 2 | 12.4 | 56.7% | 26.0 |
| 2026-03-03 | vs BKN | W | 35.0 | 11/24 | 1/7 | 0/0 | 23 | 9 | 4 | 4.8 | 47.9% | 33.0 |
| 2026-02-28 | vs HOU | W | 35.0 | 9/17 | 3/5 | 3/6 | 24 | 11 | 1 | 5.4 | 61.1% | 26.0 |
| 2026-02-26 | @ PHI | L | 36.4 | 10/20 | 4/8 | 5/8 | 29 | 14 | 3 | 8.6 | 61.6% | 36.0 |
| 2026-02-24 | @ MIL | L | 31.3 | 8/19 | 2/8 | 0/0 | 18 | 9 | 2 | -1.6 | 47.4% | 24.0 |
| 2026-02-21 | vs MEM | W | 26.9 | 4/7 | 1/3 | 4/5 | 13 | 6 | 5 | -2.1 | 70.7% | 25.0 |
| 2026-02-20 | @ ATL | W | 27.2 | 8/14 | 1/4 | 0/2 | 17 | 8 | 5 | 6.2 | 57.1% | 28.0 |
| 2026-02-11 | @ NOP | W | 37.0 | 6/19 | 2/9 | 13/17 | 27 | 14 | 4 | 8.5 | 51.0% | 38.0 |
| 2026-02-09 | vs UTA | L | 37.2 | 8/18 | 1/5 | 6/10 | 23 | 11 | 5 | 3.8 | 51.3% | 38.0 |
| 2026-02-08 | @ WAS | W | 28.1 | 9/15 | 2/6 | 2/2 | 22 | 8 | 3 | 6.5 | 69.3% | 30.0 |
| 2026-02-06 | @ BOS | L | 34.6 | 5/13 | 2/6 | 4/6 | 16 | 7 | 1 | 0.1 | 51.2% | 19.0 |
| 2026-02-03 | vs ATL | L | 30.2 | 4/16 | 0/3 | 8/8 | 16 | 14 | 1 | -0.7 | 41.0% | 18.0 |
| 2026-02-01 | vs CHI | W | 22.3 | 8/11 | 2/3 | 2/4 | 20 | 9 | 3 | 8.6 | 78.4% | 26.0 |
| 2026-01-30 | vs CHI | L | 36.4 | 7/18 | 1/8 | 6/9 | 21 | 11 | 1 | -1.7 | 47.8% | 24.0 |
| 2026-01-28 | vs ORL | L | 38.7 | 7/14 | 4/7 | 3/4 | 21 | 12 | 7 | 1.8 | 66.6% | 39.0 |
| 2026-01-25 | @ PHX | W | 32.4 | 6/16 | 2/6 | 8/8 | 22 | 7 | 1 | 4.9 | 56.4% | 24.0 |
| 2026-01-24 | @ UTA | W | 31.0 | 8/19 | 4/10 | 6/6 | 26 | 15 | 2 | 11.8 | 60.1% | 31.0 |
| 2026-01-22 | @ POR | L | 37.1 | 13/24 | 1/7 | 5/5 | 32 | 10 | 2 | 5.5 | 61.1% | 36.0 |
| 2026-01-20 | @ SAC | W | 30.4 | 8/15 | 4/5 | 5/7 | 25 | 7 | 5 | 4.9 | 69.1% | 37.0 |
| 2026-01-19 | @ GSW | L | 25.9 | 1/13 | 0/5 | 2/2 | 4 | 12 | 3 | -9.1 | 14.4% | 11.0 |
| 2026-01-17 | vs OKC | W | 32.0 | 9/22 | 6/10 | 6/6 | 30 | 12 | 4 | 8.6 | 60.9% | 40.0 |
| 2026-01-15 | vs BOS | L | 33.1 | 8/19 | 3/7 | 3/4 | 22 | 4 | 5 | 6.1 | 53.0% | 36.0 |
| 2026-01-13 | vs PHX | W | 31.6 | 11/15 | 4/6 | 3/4 | 29 | 9 | 4 | 8.0 | 86.5% | 39.0 |
| 2026-01-11 | @ OKC | L | 31.6 | 3/10 | 0/1 | 0/2 | 6 | 14 | 4 | -5.9 | 27.6% | 16.0 |
| 2026-01-10 | @ IND | L | 24.8 | 5/12 | 0/2 | 3/3 | 13 | 9 | 2 | -2.1 | 48.8% | 17.0 |
| 2026-01-08 | @ CHI | W | 33.9 | 7/19 | 2/8 | 4/4 | 20 | 12 | 2 | 1.7 | 48.2% | 24.0 |
| 2026-01-06 | @ MIN | L | 28.5 | 3/11 | 1/2 | 0/0 | 7 | 11 | 3 | -8.9 | 31.8% | 14.0 |
| 2026-01-04 | vs NOP | W | 28.8 | 5/14 | 1/3 | 1/1 | 12 | 6 | 6 | -0.4 | 41.6% | 29.0 |
| 2026-01-03 | vs MIN | L | 34.2 | 5/13 | 1/3 | 1/2 | 12 | 9 | 4 | -6.0 | 43.2% | 22.0 |
| 2026-01-01 | @ DET | W | 32.9 | 5/14 | 1/2 | 4/4 | 15 | 14 | 0 | -2.2 | 47.6% | 15.0 |
| 2025-12-29 | vs DEN | W | 21.2 | 5/10 | 1/2 | 2/2 | 13 | 10 | 4 | 4.2 | 59.7% | 23.0 |
| 2025-12-23 | vs TOR | L | 34.1 | 4/11 | 0/2 | 1/3 | 9 | 12 | 3 | -7.9 | 36.5% | 17.0 |
| 2025-12-21 | @ NYK | L | 33.6 | 4/11 | 0/3 | 6/7 | 14 | 9 | 0 | -5.2 | 49.7% | 14.0 |
| 2025-12-19 | @ BOS | L | 36.1 | 6/13 | 0/1 | 4/6 | 16 | 10 | 4 | -4.2 | 51.2% | 28.0 |
| 2025-12-18 | @ BKN | W | 31.1 | 4/13 | 0/2 | 0/2 | 8 | 17 | 1 | -2.2 | 28.8% | 10.0 |
| 2025-12-15 | vs TOR | L | 33.0 | 7/13 | 1/3 | 5/8 | 20 | 10 | 2 | 3.6 | 60.5% | 25.0 |
| 2025-12-09 | @ ORL | L | 35.5 | 7/14 | 0/3 | 5/6 | 19 | 8 | 2 | 0.9 | 57.1% | 24.0 |
| 2025-12-06 | vs SAC | L | 24.6 | 4/9 | 0/3 | 1/2 | 9 | 7 | 3 | -4.2 | 45.5% | 16.0 |
| 2025-12-05 | @ ORL | L | 39.5 | 9/15 | 2/4 | 4/6 | 24 | 15 | 3 | 2.6 | 68.0% | 31.0 |
| 2025-12-03 | @ DAL | L | 28.4 | 10/19 | 1/6 | 0/0 | 21 | 7 | 1 | 2.5 | 55.3% | 24.0 |
| 2025-12-01 | vs LAC | W | 31.6 | 10/17 | 5/8 | 2/2 | 27 | 14 | 3 | 6.1 | 75.5% | 36.0 |
| 2025-11-29 | vs DET | L | 33.2 | 5/9 | 1/2 | 4/6 | 15 | 10 | 1 | -6.8 | 64.4% | 17.0 |
| 2025-11-26 | vs MIL | W | 28.6 | 7/16 | 1/5 | 2/2 | 17 | 11 | 2 | -1.2 | 50.4% | 21.0 |
| 2025-11-24 | vs DAL | W | 29.3 | 5/13 | 0/3 | 7/11 | 17 | 6 | 1 | 0.6 | 47.6% | 20.0 |
| 2025-11-23 | @ PHI | W | 32.5 | 7/14 | 1/4 | 3/4 | 18 | 13 | 1 | -0.8 | 57.1% | 20.0 |
| 2025-11-21 | @ CHI | W | 29.4 | 4/11 | 2/5 | 8/10 | 18 | 7 | 5 | 5.6 | 58.4% | 29.0 |
| 2025-11-19 | vs GSW | W | 28.8 | 7/13 | 3/4 | 3/3 | 20 | 7 | 3 | 2.9 | 69.8% | 27.0 |
| 2025-11-05 | @ DEN | L | 8.2 | 1/5 | 0/2 | 0/0 | 2 | 1 | 0 | -3.3 | 20.0% | 2.0 |
| 2025-11-03 | @ LAC | W | 30.2 | 10/18 | 2/4 | 3/5 | 25 | 10 | 4 | 5.5 | 61.9% | 34.0 |
| 2025-11-02 | @ LAL | L | 36.3 | 6/11 | 1/5 | 4/4 | 17 | 8 | 5 | -6.5 | 66.6% | 28.0 |
| 2025-10-30 | @ SAS | L | 37.2 | 12/27 | 4/13 | 3/4 | 31 | 10 | 3 | 10.4 | 53.9% | 38.0 |
| 2025-10-28 | vs CHA | W | 30.3 | 10/16 | 3/5 | 3/4 | 26 | 6 | 2 | -3.6 | 73.2% | 32.0 |
| 2025-10-26 | vs NYK | W | 38.3 | 5/15 | 1/5 | 8/8 | 19 | 13 | 3 | 0.3 | 51.3% | 25.0 |
| 2025-10-24 | @ MEM | W | 28.4 | 8/19 | 4/8 | 4/4 | 24 | 5 | 4 | 5.5 | 57.8% | 35.0 |
| 2025-10-22 | @ ORL | L | 34.2 | 4/13 | 1/5 | 6/7 | 15 | 12 | 2 | -2.0 | 46.6% | 19.0 |